Novartis Acquisitions

Novartis has acquired 34 companies and its latest acquisition was Anthos Therapeutics, Inc. on Feb 2025

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Anthos Therapeutics, Inc.

Feb 2025

Source »
$925M
-
Kate Therapeutics, Inc.

Nov 2024

Source »
$1.1B
Kate Therapeutics is a California-based biotechnology company that researches and develops AAV-based gene therapeutics for the treatment of muscle and heart diseases.
Mariana Oncology, Inc.

May 2024

Source »
$1B
Mariana is a Massachusetts-based biotechnology company that researches and develops peptide-based radiopharmaceuticals for the treatment of cancer.

-

IFM Due, Inc

Mar 2024

Source »
$90M
-
MorphoSys AG

Feb 2024

Source »
$2.9B
MorphoSys is a Germany-based biopharmaceutical company that researches and develops oncology medicines for the treatment of cancer.

Frequently Asked Questions about Novartis

  1. What companies did Novartis acquire?

    Companies acquired by Novartis include Anthos Therapeutics, Kate Therapeutics and Mariana Oncology
  2. How many acquisitions does Novartis have?

    Novartis has acquired 34 companies including Anthos Therapeutics, Kate Therapeutics and Mariana Oncology.
  1. How many acquisitions did Novartis make in 2025?

    In 2025 Novartis acquired 1 companies including Anthos Therapeutics.